NCT05847686: Psilocybin-Assisted Therapy for the Treatment of Cancer-Related Anxiety in Patients With Metastatic Cancer
- State
- Completed
- Phase
- Phase 1 and Phase 2
- People
- 55 taking part
- Started
- 27 Jun 2023
- Primary completion
- 8 Apr 2024
- Arms
- Treatment (psilocybin, therapy)
- Results
- Posted on the registry
- 8 May 2023: Trial registered
- 27 Jun 2023: Trial started
- 17 Oct 2024: Trial completed
- 30 Apr 2025: Trial results posted